(Q46289900)

English

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

scientific article published in August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

cortical bone thickness

0 references

0 references

author name string

Hodsman AB

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Kisiel M

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Adachi JD

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Fraher LJ

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Watson PH

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

27

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

311-318

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Trabecular bone remodeling and balance in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Photon absorptiometric analysis of bone density in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Skeletal disease in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Trabecular bone structure in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900316-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S8756-3282(00)00316-1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

release_wgpvvwc55jhjjjexupodv6cyhm

1 reference

https://api.fatcat.wiki/v0/release/wgpvvwc55jhjjjexupodv6cyhm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10913928

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46289900&oldid=2103627080"